{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T06:38:14Z","timestamp":1725518294921},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1007\/s00105-005-1009-3","type":"journal-article","created":{"date-parts":[[2005,8,18]],"date-time":"2005-08-18T12:44:48Z","timestamp":1124369088000},"page":"871-887","source":"Crossref","is-referenced-by-count":32,"title":["Rosazea","Rosacea"],"prefix":"10.1007","volume":"56","author":[{"given":"P.","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1009_CR1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1346-8138.1992.tb03227.x","volume":"19","author":"Aizawa","year":"1992","unstructured":"Aizawa H, Niimura M (1992) Oral spironolactone therapy in male patients with rosacea. J Dermatol 19:293\u2013297","journal-title":"J Dermatol"},{"key":"1009_CR2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-4632.2004.02130.x","volume":"44","author":"Altinyazar","year":"2005","unstructured":"Altinyazar HC, Koca R, Tekin NS, Esturk E (2005) Adapalene vs. Metronidazole gel for the treatment of rosacea. Int J Dermatol 44:252\u2013255","journal-title":"Int J Dermatol"},{"key":"1009_CR3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/106002808702100410","volume":"21","author":"Aronson","year":"1987","unstructured":"Aronson IK, Rumsfield JA, West DP et al. (1987) Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharmacol 21:346\u2013351","journal-title":"Drug Intell Clin Pharmacol"},{"key":"1009_CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0190-9622(87)80138-X","volume":"16","author":"Ayres","year":"1987","unstructured":"Ayres S Jr (1987) Extrafacial rosacea is rare but does exist. J Am Acad Dermatol 16:391\u2013392","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR5","first-page":"933","volume":"22","author":"Majdekoff","year":"1968","unstructured":"Majdekoff B (1968) Die Behandlung der Rosazea mit Breitspektrum-Antibiotika. Z Hautkr 22:933","journal-title":"Z Hautkr"},{"key":"1009_CR6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archderm.135.6.659","volume":"135","author":"Bamford","year":"1999","unstructured":"Bamford JT, Tilden RL, Blankush JL, Gangeness DE (1999) Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 135:659\u2013663","journal-title":"Arch Dermatol"},{"key":"1009_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0190-9622(03)02157-1","volume":"50","author":"Bamford","year":"2004","unstructured":"Bamford JT, Elliott BA, Haller IV (2004) Tacrolimus effect on rosacea. J Am Acad Dermatol 50:107\u2013108","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR8","doi-asserted-by":"crossref","unstructured":"Barker DJ, Gould DJ (1978) A pustular eruption of the chin (a variant of pyoderma faciale?) Acta Dermatol Venereol 58:549\u2013551","DOI":"10.2340\/0001555558549551"},{"key":"1009_CR9","first-page":"419","volume":"69","author":"Berg","year":"1989","unstructured":"Berg M, Liden S (1989)An epidemiological study of rosacea. Acta Derm Venereol 69:419\u2013423","journal-title":"Acta Derm Venereol"},{"key":"1009_CR10","first-page":"27","volume":"75","author":"Bikowski","year":"2005","unstructured":"Bikowski JB (2005) The pharmacologic therapy of rosacea: a paradigm shift in progress. Cutis 75:27\u201332","journal-title":"Cutis"},{"key":"1009_CR11","first-page":"187","volume":"26","author":"Bjerke","year":"1989","unstructured":"Bjerke JR, Nyfors A, Austad J et al. (1989) Metronidazole (Elyzol) 1% cream vs placebo cream in the treatment of rosacea. Clin Trials 26:187\u2013194","journal-title":"Clin Trials"},{"key":"1009_CR12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.1987.01660290077020","volume":"123","author":"Bleicher","year":"1987","unstructured":"Bleicher PA, Charles JH, Sober AJ (1987) Topical metronidazole therapy for rosacea. Arch Dermatol 123:609\u2013614","journal-title":"Arch Dermatol"},{"key":"1009_CR13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1468-3083.2001.00325.x","volume":"15","author":"Bormann","year":"2002","unstructured":"Bormann G, Gaber G, Fischer M, Marsch WC (2002) Dapsone in rosacea fulminans. J Eur Acad Dermatol Venereol 15:465\u2013467","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1009_CR14","first-page":"44","volume":"61","author":"Breneman","year":"1998","unstructured":"Breneman DL, Stewart D, Hevia O et al. (1998) A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea. Cutis 61:44\u201347","journal-title":"Cutis"},{"key":"1009_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF00424276","volume":"281","author":"Brinnel","year":"1989","unstructured":"Brinnel H, Friedel J, Caputa M et al. (1989) Rosacea: disturbed defense against brain overheating. Arch Dermatol Res 281:66\u201372","journal-title":"Arch Dermatol Res"},{"key":"1009_CR16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2133.1955.tb12676.x","volume":"67","author":"Brodthagen","year":"1955","unstructured":"Brodthagen H (1955) Mepacrine and chloroquine in the treatment of rosacea. Br J Dermatol 67:421\u2013425","journal-title":"Br J Dermatol"},{"key":"1009_CR17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000082564","volume":"210","author":"Buechner","year":"2005","unstructured":"Buechner SA (2005) Rosacea. an update. Dermatology 210:100\u2013108","journal-title":"Dermatology"},{"key":"1009_CR18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2133.2005.06404.x","volume":"152","author":"Chu","year":"2005","unstructured":"Chu CY (2005) The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea. Br J Dermatol 152:396\u2013399","journal-title":"Br J Dermatol"},{"key":"1009_CR19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/bmj.1.6053.105","volume":"I","author":"Cunliffe","year":"1977","unstructured":"Cunliffe WJ, Dodman B, Binner JG (1977) Clonidine and facial flushing in rosacea. Br Med J I:105","journal-title":"Br Med J"},{"key":"1009_CR20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","volume":"51","author":"Crawford","year":"2004","unstructured":"Crawford GH, Pelle MT, James WD (2004) Rosacea. I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 51:327\u2013341","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2133.1987.tb12084.x","volume":"117","author":"Cunliffe","year":"1993","unstructured":"Cunliffe WJ, Rowell NR (1993) Pyoderma faciale. Br J Dermatol 117(32):96\u201397","journal-title":"Br J Dermatol"},{"key":"1009_CR22","doi-asserted-by":"crossref","unstructured":"Czernielewski J, Liu Y (2004) Comparison of 15% azelaic acid gel and 0,75% metronidazole gel for the topical treatment of papulopustular rosacea","DOI":"10.1001\/archderm.140.10.1282-b"},{"key":"1009_CR23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archderm.134.6.679","volume":"134","author":"Dahl","year":"1998","unstructured":"Dahl MV, Katz I, Krueger GG et al. (1998) Topical metronidazole maintains remissions of rosacea. Arch Dermatol 134:679\u2013683","journal-title":"Arch Dermatol"},{"key":"1009_CR24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0926-9959(98)95615-X","volume":"11","author":"Dreno","year":"1998","unstructured":"Dreno B, Bubertret L, Naeyaert JM et al. (1998) Comparison of the clinical efficacy and safety of metronidazole 0,75 cream with metronidazole 0,75% gel in the treatment of rosacea. J Euro Acad Dermatol Venereol 11:272\u2013273","journal-title":"J Euro Acad Dermatol Venereol"},{"key":"1009_CR25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0190-9622(86)80104-9","volume":"15","author":"Dupont","year":"1986","unstructured":"Dupont C (1986) The role of sunshine in rosacea. J Am Acad Dermatol 15:713\u2013714","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR26","doi-asserted-by":"crossref","unstructured":"Elewski BE, Fleischer AB Jr, Pariser DM (2003) A comparison of 15% azelaic acid gel and 0,75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial","DOI":"10.1001\/archderm.139.11.1444"},{"key":"1009_CR27","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archderm.134.7.884","volume":"134","author":"Erdoan","year":"1998","unstructured":"Erdoan FG, Yurtsever P, Aksoy D, Eskioglu F (1998) Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 134:884\u2013885","journal-title":"Arch Dermatol"},{"key":"1009_CR28","first-page":"129","volume":"120","author":"Espagne","year":"1993","unstructured":"Espagne E, Guillaume JC, Archimbaud A et al. (1993) Double-blind study versus exipient of 0,75% metronidazole gel in the treatment of rosacea. Ann Dermatol Venereol 120:129\u2013133","journal-title":"Ann Dermatol Venereol"},{"key":"1009_CR29","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2133.1993.tb00261.x","volume":"128","author":"Forton","year":"1993","unstructured":"Forton F, Seys B (1993) Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol 128:650\u2013659","journal-title":"Br J Dermatol"},{"key":"1009_CR30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006534-197009000-00010","volume":"46","author":"Freeman","year":"1970","unstructured":"Freeman BS (1970) Reconstructive rhinoplasty of rhinophyma. Plst Reconst Surg 46:265\u2013270","journal-title":"Plst Reconst Surg"},{"key":"1009_CR31","first-page":"169","volume":"16","author":"Friederich","year":"1967","unstructured":"Friederich HC (1967) Zur Therapie des Rhinophyms. Aesth Med 16:169\u2013182","journal-title":"Aesth Med"},{"key":"1009_CR32","first-page":"22","volume":"75","author":"Goldberg","year":"2005","unstructured":"Goldberg DJ (2005) Lasers and lights sources for rosacea. Cutis 75:22\u201326","journal-title":"Cutis"},{"key":"1009_CR33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1468-3083.1997.tb00196.x","volume":"8","author":"Greaves","year":"1997","unstructured":"Greaves MW, Burova E (1997) Flushing: causes, investigation and clinical consequences. J Eur Acad Dermatol Venereol 8:91\u2013100","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1009_CR34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00509061","volume":"272","author":"Guerrera","year":"1982","unstructured":"Guerrera M, Parodi A, Cipriani C et al. (1982) Flushing in rosacea: a possible mechanism. Arch Dermatol Res 272:311\u2013316","journal-title":"Arch Dermatol Res"},{"key":"1009_CR35","first-page":"1","volume":"7","author":"Gupta","year":"2002","unstructured":"Gupta AK, Chaudhry M (2002) Topical metronidazole for rosacea. Skin Ther Lett 7:1\u20133, 6","journal-title":"Skin Ther Lett"},{"key":"1009_CR36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3346\/jkms.2000.15.5.551","volume":"15","author":"Herr","year":"2000","unstructured":"Herr H, You CH (2000) Relationship between Helicobacter pylori and rosacea: it may be a myth. J Korean Med Sci 15:551\u2013554","journal-title":"J Korean Med Sci"},{"key":"1009_CR37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaad.2004.03.012","volume":"51","author":"Heymann","year":"2004","unstructured":"Heymann WR (2004) Rosacea subtype-directed therapy. J Am Acad Dermatol 51:90\u201392","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR38","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s001050050341","volume":"46","author":"H\u00f6lzle","year":"1995","unstructured":"H\u00f6lzle E, Jansen T, Plewig G (1995) Morbus Morbihan \u2014 Chronisch persistierendes \u00d6dem des Gesichtes. Hautarzt 46:796\u2013798","journal-title":"Hautarzt"},{"key":"1009_CR39","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-4362.1986.tb04533.x","volume":"25","author":"Hoting","year":"1986","unstructured":"Hoting E, Paul E, Plewig G (1986) Treatment of rosacea with isotretinoin. Int J Dermatol 25:660\u2013663","journal-title":"Int J Dermatol"},{"key":"1009_CR40","unstructured":"Jansen T, Plewig G (1993) H\u00e4ufig verkannt: Rosacea fulminans. Dtsch \u00c4rztebl 90:1784\u20131787"},{"key":"1009_CR41","first-page":"212","volume":"20","author":"Jansen","year":"1994","unstructured":"Jansen T, Plewig G (1994) Rosacea fulminans. Therapie mit Kortikosteroiden und Isotretinoin. Akt Dermatol 20:212\u2013216","journal-title":"Akt Dermatol"},{"key":"1009_CR42","first-page":"381","volume":"20","author":"Jansen","year":"1994","unstructured":"Jansen T, Melnik B, Plewig G (1994) Gramnegative Follikulitis als Begleitkomplikation bei Rosazea. Akt Dermatol 20:381\u2013384","journal-title":"Akt Dermatol"},{"key":"1009_CR43","unstructured":"Jansen T, Plewig G, (1996) Klinik und Therapie der Rosazea. H+G 71:88\u201395"},{"key":"1009_CR44","unstructured":"Jansen T, Plewig G (1996) Pathogenese der Rosazea: Fakten und Mythen. H+G 71:8\u201314"},{"key":"1009_CR45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/014107689709000308","volume":"90","author":"Jansen","year":"1997","unstructured":"Jansen T, Plewig G (1997) Rosacea: classification and treatment. J R Soc Med 90:144\u2013150","journal-title":"J R Soc Med"},{"key":"1009_CR46","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s001050050851","volume":"49","author":"Jansen","year":"1999","unstructured":"Jansen T, Regele D, Schirren CG et al. (1999) Persistierendes Erythem und \u00d6dem des Gesichts bei Rosazea und Lymphgef\u00e4\u00dfdysplasie. Hautarzt 49:932\u2013935","journal-title":"Hautarzt"},{"key":"1009_CR47","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0190-9622(98)70337-8","volume":"39","author":"Jorizzo","year":"1998","unstructured":"Jorizzo JL, Lebwohl M, Tobey RE (1998) The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their verhicles in rosacea: a double-blind clinical trial. J Am Acad Dermatol 39:502\u2013504","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR48","doi-asserted-by":"crossref","unstructured":"Karge HJ (1977) Rhinophym: Dermatochirurgische M\u00f6glichkeiten zur Behandlung. In: Konz B, Burg G (Hrsg) Dermatochirurgie in Klinik und Praxis, Bd I. Springer, Berlin Heidelberg New York, S 195\u2013201","DOI":"10.1007\/978-3-642-66555-4_26"},{"key":"1009_CR49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000065849","volume":"205","author":"Kocak","year":"2002","unstructured":"Kocak M, Yagli S, Vahapoglu G, Eksioglu M (2002) Permethrin 5% Cream versus Metronidazol 0,75% Gel for the treatment of papulo-pustular rosacea. A randomized double-blind placebo-controlled study. Dermatology 205:265\u2013270","journal-title":"Dermatology"},{"key":"1009_CR50","first-page":"519","volume":"2","author":"Koch","year":"1996","unstructured":"Koch R, Wilbrand G (1996) Oral treatment of rosacea with sodium bituminosulphonate. Derm 2:519\u2013525","journal-title":"Derm"},{"key":"1009_CR51","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s001050050577","volume":"48","author":"Krause","year":"1997","unstructured":"Krause MH, Torricelli R, Kundig T et al. (1997) Dapson bei granulomat\u00f6ser Rosazea. Hautarzt 48:246\u2013248","journal-title":"Hautarzt"},{"key":"1009_CR52","first-page":"495","volume":"11","author":"Lattke","year":"1995","unstructured":"Lattke C (1995) Wirksamkeit und Vertr\u00e4glichkeit von Natriumbituminosulfonat dunkel bei 20 Patienten mit Rosazea. Hautnah Dermatol 11:495\u2013500","journal-title":"Hautnah Dermatol"},{"key":"1009_CR53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/1523-1747.ep12543603","volume":"81","author":"Lehmann","year":"1983","unstructured":"Lehmann P, Zheng P, Lavker RM, Kligman AM (1983) Corticosteroid atrophy in human skin. A study by light, scanning, and transmission electron microscopy. J Invest Dermatol 81:169\u2013176","journal-title":"J Invest Dermatol"},{"key":"1009_CR54","doi-asserted-by":"crossref","unstructured":"Lehmann P, Arens A (2000) Rosacea fulminans. In: Plettenberg A, Meigel WN, Moll I (Hrsg) Dermatologie an der Schwelle zum neuen Jahrtausend. Springer, Berlin Heidelberg New York Tokyo, S 257\u2013259","DOI":"10.1007\/978-3-642-57191-6_69"},{"key":"1009_CR55","first-page":"Rosazea","volume":"Rosazea","author":"Lehmann","year":"2003","unstructured":"Lehmann P (2003) Klinische Studien zur topischen Therapie mit Metronidazol bei Rosazea: Rosazea \u2013 Klinik und aktuelle Therapie S 41\u201350","journal-title":"Klinische Studien zur topischen Therapie mit Metronidazol bei"},{"key":"1009_CR56","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/archderm.1974.01630100075019","volume":"111","author":"Leyden","year":"1974","unstructured":"Leyden JJ, Thew M, Kligman AM (1974) Steroid rosacea. Arch Dermatol 111:619\u2013622","journal-title":"Arch Dermatol"},{"key":"1009_CR57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1468-3083.2002.00388_2.x","volume":"16","author":"Ljubojeviae","year":"2002","unstructured":"Ljubojeviae S, Basta-Juzbasiae A, Lipozeneiae J (2002) Steroid dermatitis resembling rosacea: aetiopathogenesis and treatment. J Eur Acad Dermatol Venereol 16:121\u2013126","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1009_CR58","first-page":"283","volume":"43","author":"Lowe","year":"1989","unstructured":"Lowe H, Henderson T, Millikan LE et al. (1989) Topical metronidazole for severe and recalcitrant rosacea: a prospective open trial. Therapeutics Clinician 43:283\u2013286","journal-title":"Therapeutics Clinician"},{"key":"1009_CR59","first-page":"25","volume":"74","author":"Mackley","year":"2005","unstructured":"Mackley CL, Thiboutot DM (2005) Diagnosing and managing the patients with rosacea. Cutis 74:25\u201329","journal-title":"Cutis"},{"key":"1009_CR60","first-page":"740","volume":"7","author":"Maddin","year":"1995","unstructured":"Maddin WS, Schachter D, McElgunn PS et al. (1995) Open, non-comparative evaluation of topical metronidazole in the treatment of moderate and severe rosacea. Canadian J Dermatol 7:740\u2013744","journal-title":"Canadian J Dermatol"},{"key":"1009_CR61","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(99)70085-X","volume":"40","author":"Maddin","year":"1999","unstructured":"Maddin S (1999) A comparison of topical azelaic acid 20% cream and topical metronidazole 0,75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 40:961\u2013965","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR62","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2230.1984.tb00842.x","volume":"9","author":"Marsden","year":"1984","unstructured":"Marsden JR, Shuster S, Neugebauer M (1984) Response of rosacea to isotretinoin. Clin Exp Deramtol 9:484\u2013488","journal-title":"Clin Exp Deramtol"},{"key":"1009_CR63","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0190-9622(87)80498-X","volume":"17","author":"Marks","year":"1987","unstructured":"Marks VJ, Briggaman RA (1987) Pyoderma faciale: Succesful treatment with isotretinoin. J Am Acad Dermatol 17:1062\u20131063","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.1968.tb12288.x","volume":"80","author":"Marks","year":"1968","unstructured":"Marks R (1968) Concepts in the pathogenesis of rosacea. Br J Dermatol 80:170\u2013171","journal-title":"Br J Dermatol"},{"key":"1009_CR65","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(71)90376-X","volume":"II","author":"Marks","year":"1971","unstructured":"Marks R, Ellis J (1971) Comparative effectiveness of tetracycline and ampicillin in rosacea: a controlled trial. Lancet II:1049\u20131052","journal-title":"Lancet"},{"key":"1009_CR66","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00006534-196210000-00002","volume":"30","author":"Matton","year":"1962","unstructured":"Matton G, Pickrell K, Huger W, Pound E (1962) The surgical treatment of rhinophyma. Plast Reconstr Surg 30:403\u2013414","journal-title":"Plast Reconstr Surg"},{"key":"1009_CR67","first-page":"94","volume":"32","author":"Mauss","year":"1981","unstructured":"Mauss J (1981) Behandlung der papulopustul\u00f6sen Rosazea der Frau mit Zyproteronacetat. Hautarzt 32:94\u201395","journal-title":"Hautarzt"},{"key":"1009_CR68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00128071-200001030-00007","volume":"1","author":"McClellan","year":"2000","unstructured":"McClellan K, Noble S (2000) Topical metronidazole. A review of its use in rosacea. Am J Clin Dermatol 1:191\u2013199","journal-title":"Am J Clin Dermatol"},{"key":"1009_CR69","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09546639109092728","volume":"2","author":"Monk","year":"1991","unstructured":"Monk BE, Logan RA, Cook J et al. (1991) Topical metronidazole in the treatment of rosacea. J Dermatol Treat 2:91\u201393","journal-title":"J Dermatol Treat"},{"key":"1009_CR70","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0306-9877(98)90019-6","volume":"50","author":"Nagasaki","year":"1998","unstructured":"Nagasaki T, Brinnel H, Hales JR, Ogawa T (1998) Selective brain cooling in hyperthermia: the mechanisms and medical implications. Med Hypotheses 50:203\u2013211","journal-title":"Med Hypotheses"},{"key":"1009_CR71","doi-asserted-by":"crossref","unstructured":"Neumann NJ, Lehmann P (2000) Photodermatosen: Ein Leitfaden zur Diagnostik. Steinkopff, Darmstadt","DOI":"10.1007\/978-3-662-12686-8"},{"key":"1009_CR72","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.1983.tb04003.x","volume":"109","author":"Nielsen","year":"1983","unstructured":"Nielsen PG (1983) The relapse rate for rosacea after treatment with either oral tetracycline or metronidazole cream. Br J Dermatol 109:122\u2013123","journal-title":"Br J Dermatol"},{"key":"1009_CR73","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2133.1983.tb03972.x","volume":"108","author":"Nielsen","year":"1983","unstructured":"Nielsen PG (1983) Treatment of rosacea with 1% metronidazole cream: a double-blind study. Br J Dermatol 108:327\u2013332","journal-title":"Br J Dermatol"},{"key":"1009_CR74","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2133.1983.tb03993.x","volume":"109","author":"Nielsen","year":"1986","unstructured":"Nielsen PG (1986) A double-blind study of 1% metronidazole cream versus systemic ocxytetracycline therapy for rosacea. Br J Dermatol 109:63\u201365","journal-title":"Br J Dermatol"},{"key":"1009_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-4362.1988.tb02323.x","volume":"27","author":"Nielsen","year":"1988","unstructured":"Nielsen PG (1988) Metronidazole treatment in rosacea. Int J Dermatol 27:1\u20135","journal-title":"Int J Dermatol"},{"key":"1009_CR76","first-page":"660","volume":"31","author":"Nikolowski","year":"1980","unstructured":"Nikolowski J, Plewig G (1980) Rosazea. Orale Behandlung mit 13-cis-Retins\u00e4ure. Hautarzt 31:660\u2013661","journal-title":"Hautarzt"},{"key":"1009_CR77","first-page":"575","volume":"32","author":"Nikolowski","year":"1981","unstructured":"Nikolowski J, Plewig G (1981) Orale Behandlung der Rosazea mit 13-cis-Retins\u00e4ure. Hautarzt 32:575\u2013584","journal-title":"Hautarzt"},{"key":"1009_CR78","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archderm.1940.01490090003001","volume":"41","author":"O\u2019Leary","year":"1940","unstructured":"O\u2019Leary PA, Kierland RR (1940) Pyoderma faciale. Arch Dermatol 41:451\u2013462","journal-title":"Arch Dermatol"},{"key":"1009_CR79","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2230.2003.01179.x","volume":"28","author":"Oztas","year":"2003","unstructured":"Oztas MO, Balk M, Ogus E et al. (2003) The role of free oxygen radicals in the aetiopathogenesis of rosacea. Clin Exp Dermatol 28:188\u2013192","journal-title":"Clin Exp Dermatol"},{"key":"1009_CR80","first-page":"141","volume":"72","author":"Pabby","year":"2003","unstructured":"Pabby A, An KP, Laws RA (2003) Combination therapy of tetracycline and tacrolimus resulting in rapid resolution of steroid-induced periocular rosacea. Cutis 72:141\u2013142","journal-title":"Cutis"},{"key":"1009_CR81","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2004.03.033","volume":"51","author":"Pelle","year":"2004","unstructured":"Pelle MT, Crawford GH, James WD (2004) Rosacea. II. Therapy. J Am Acad Dermatol 51:499\u2013512","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR82","doi-asserted-by":"crossref","unstructured":"Petres J (1977) Dermabrasion. In: Konz B, Burg G (Hrsg) Dermatochirurgie in Klinik und Praxis, Bd I. Springer, Berlin Heidelberg New York, S 211\u2013213","DOI":"10.1007\/978-3-642-66555-4_29"},{"key":"1009_CR83","first-page":"433","volume":"36","author":"Petres","year":"1985","unstructured":"Petres J (1985) Therapie des Rhinophyms. Hautarzt 36:433\u2013435","journal-title":"Hautarzt"},{"key":"1009_CR84","doi-asserted-by":"crossref","unstructured":"Plewig G, Kligman AM (2000) Acne and Rosacea, 3rd edn. Springer, Berlin Heidelberg New York Tokyo, p 365","DOI":"10.1007\/978-3-642-59715-2_30"},{"key":"1009_CR85","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/archderm.1992.04530010049007","volume":"128","author":"Plewig","year":"1992","unstructured":"Plewig G, Jansen T, Kligman AM (1992) Pyoderma faciale \u2014 a review and report of 20 additional acses: Is it rosaea? Arch Dermatol 128:1611\u20131617","journal-title":"Arch Dermatol"},{"key":"1009_CR86","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0190-9622(08)80863-8","volume":"28","author":"Powell","year":"1993","unstructured":"Powell FC, Corbally N, Powell D (1993) Substance P and rosacea. J Am Acad Dermatol 28:132\u2013133","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR87","first-page":"9","volume":"74","author":"Powell","year":"2004","unstructured":"Powell FC (2004) Rosacea and the pilosebaceous follicle. Cutis 74:9\u201312, 32\u201334","journal-title":"Cutis"},{"key":"1009_CR88","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMcp042829","volume":"352","author":"Powell","year":"2005","unstructured":"Powell FC (2005) Clinical practice. Rosacea. N Engl J Med 352:795\u2013803","journal-title":"N Engl J Med"},{"key":"1009_CR89","first-page":"181","volume":"59","author":"Prinz","year":"1984","unstructured":"Prinz L (1984) Zur Behandlung der Rosazea mit Metronidazol innerlich und \u00e4u\u00dferlich. Z Hautk 59:181\u2013183","journal-title":"Z Hautk"},{"key":"1009_CR90","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(76)92160-7","volume":"I","author":"Pye","year":"1976","unstructured":"Pye RJ, Burton JL (1976) Treatment of rosacea by metronidazole. Lancet I:1211\u20131212","journal-title":"Lancet"},{"key":"1009_CR91","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1468-3083.2000.00132.x","volume":"14","author":"Rebora","year":"2000","unstructured":"Rebora AE (2000) Helicobacter pylori and rosacea. J Eur Acad Dermatol Venereol 14:344","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1009_CR92","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/00128071-200203070-00005","volume":"3","author":"Rebora","year":"2002","unstructured":"Rebora A (2002) The management of rosacea. Am J Clin Dermatol 3:489\u2013496","journal-title":"Am J Clin Dermatol"},{"key":"1009_CR93","first-page":"211","volume":"19","author":"Richter","year":"1995","unstructured":"Richter R, Tat L (1995) Untersuchungen zur Therapie der Rosazea mit Resochin. Z Hautkr 19:211\u2013215","journal-title":"Z Hautkr"},{"key":"1009_CR94","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1600-0560.1998.tb01739.x","volume":"25","author":"Roihu","year":"1998","unstructured":"Roihu T, Kariniemi AL (1998) Demodex mites in acne rosacea. J Cutan Pathol 25:550\u2013552","journal-title":"J Cutan Pathol"},{"key":"1009_CR95","first-page":"331","volume":"13","author":"Ruzicka","year":"2003","unstructured":"Ruzicka T, Assmann T, Lebwohl M (2003) Potential future dermatological indications for tacrolimus ointment. Eur J Dermatol 13:331\u2013342","journal-title":"Eur J Dermatol"},{"key":"1009_CR96","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2133.1980.tb06558.x","volume":"102","author":"Saihan","year":"1980","unstructured":"Saihan EM, Burton JL (1980) A double-blind trial of metronidazole versus oxytetracycline therapy of rosacea. Br J Dermatol 102:443\u2013445","journal-title":"Br J Dermatol"},{"key":"1009_CR97","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/09546639709160276","volume":"8","author":"Sauder","year":"1997","unstructured":"Sauder DN, Miller R, Gratton D et al. (1997) The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study. J Dermatol Treat 8:79\u201385","journal-title":"J Dermatol Treat"},{"key":"1009_CR98","doi-asserted-by":"crossref","unstructured":"Savin JA, Alexander S, Marks R (1972) Rosacealike eruption of children. Br J Dermatol 425\u2013429","DOI":"10.1111\/j.1365-2133.1972.tb01589.x"},{"key":"1009_CR99","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF03259568","volume":"3","author":"Schachter","year":"1991","unstructured":"Schachter D, Schachter RK, Long B et al. (1991) Comparison of metronidazole 1% cream versus oral tetracycline in patients with rosacea. Drug Invest 3:220\u2013224","journal-title":"Drug Invest"},{"key":"1009_CR100","first-page":"1123","volume":"62","author":"Schell","year":"1987","unstructured":"Schell H, Vogt HJ, Mackk-Hennes A (1987) Behandlung der Rosazea mit Istotretinoin. Ergebnisse einer posttherapeutischen multizentrischen Verlaufsbeobachtung. Z Hautkr 62:1123\u20131133","journal-title":"Z Hautkr"},{"key":"1009_CR101","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s00105-003-0532-3","volume":"54","author":"Schindera","year":"2003","unstructured":"Schindera N, Deutsch J, Quinkenstein E, Schindera I (2003) The restored masterwork. The old man, his rhinophyma and the child. Hautarzt 54:548\u2013549","journal-title":"Hautarzt"},{"key":"1009_CR102","first-page":"27","volume":"7","author":"Schirner","year":"1981","unstructured":"Schirner A, Haneke E (1981) Rosacea and metronidazole. Acta Dermatol 7:27\u201330","journal-title":"Acta Dermatol"},{"key":"1009_CR103","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2340\/00015555641521","volume":"64","author":"Schmidt","year":"1984","unstructured":"Schmidt JB, Gerhard W, Raff M, Spona J (1984) 13-cis-retinoid acid in rosacea: clinical and laboratory findings. Acta Derm Venereol 64:15\u201321","journal-title":"Acta Derm Venereol"},{"key":"1009_CR104","first-page":"115","volume":"94","author":"Schmidt","year":"1982","unstructured":"Schmidt JB, Raff M (1982) 13-cis Retins\u00e4ure: Eine neue Behandlungsform der Rosazea. Wien Klin Wochenschr 94:115\u2013118","journal-title":"Wien Klin Wochenschr"},{"key":"1009_CR105","doi-asserted-by":"crossref","unstructured":"Sch\u00f6fer H (2003) Rosazea: Klinik und aktuelle Therapie. Georg Thieme, Stuttgart New York","DOI":"10.1055\/b-002-29659"},{"key":"1009_CR106","unstructured":"Sch\u00f6fer H (2003) Rosazea \u2014 Pathogenese, klinisches Bild, Differentialdiagnose und Komplikationen. In: Sch\u00f6fer H (Hrsg) Roszea \u2014 Klinik und aktuelle Therapie S 5\u2013190"},{"key":"1009_CR107","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0190-9622(92)70086-U","volume":"26","author":"Sibenge","year":"1992","unstructured":"Sibenge S, Gawkrodger DJ (1992) Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol 26:590\u2013593","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR108","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/0140-6736(91)90318-J","volume":"337","author":"Skrlin","year":"1991","unstructured":"Skrlin J, Richter B, Basta-Juzbasic A et al. (1991) Demodicosis and rosacea. Lancet 337:734","journal-title":"Lancet"},{"key":"1009_CR109","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.1966.tb12168.x","volume":"78","author":"Sneddon","year":"1966","unstructured":"Sneddon IB (1966) A clinical trail of tetracycline in rosacea. Br J Dermatol 78:649\u2013652","journal-title":"Br J Dermatol"},{"key":"1009_CR110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/01.icu.0000143683.14738.76","volume":"15","author":"Stone","year":"2004","unstructured":"Stone DU, Chodosh J (2004) Ocular rosacea: an update on pathogenesis and therapy. Curr Opin Ophthalmol 15:499\u2013502","journal-title":"Curr Opin Ophthalmol"},{"key":"1009_CR111","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1468-3083.2002.00497.x","volume":"16","author":"Szlachcic","year":"2002","unstructured":"Szlachcic A (2002) The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol 16:328\u2013333","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1009_CR112","first-page":"epub","volume":"13","author":"Tan","year":"2002","unstructured":"Tan JK, Girard C, Krol A et al. (2002) Randomized placebo-controlled trial of Metronidazol 1% cream with sunscreen SPF 15 in treatment of rosacea. J Cutan Med Surg 13: epub ahead of print","journal-title":"J Cutan Med Surg"},{"key":"1009_CR113","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1046\/j.1365-4362.1997.00301.x","volume":"36","author":"Torresani","year":"1997","unstructured":"Torresani C, Baroni E, Manara GC (1997) Clinical trial on clarithromycin versus doxycycline in the treatment of rosacea. Int J Dermatol 36:938\u2013946","journal-title":"Int J Dermatol"},{"key":"1009_CR114","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-4362.1998.00442.x","volume":"37","author":"Torresani","year":"1998","unstructured":"Torresani C (1998) Clarithromycin: a new perspective in rosacea treatment. Int J Dermatol 37:347\u2013349","journal-title":"Int J Dermatol"},{"key":"1009_CR115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2340\/00015555678991","volume":"67","author":"Turjanmaa","year":"1987","unstructured":"Turjanmaa K, Reunala T (1987) Isotretinoin treatment of rosaea. Acta Derm Venereol 67:89\u201391","journal-title":"Acta Derm Venereol"},{"key":"1009_CR116","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1468-3083.1997.tb00469.x","volume":"8","author":"Utas","year":"1997","unstructured":"Utas S, \u00dcmit \u00dc (1997) Treatment of rosacea with ketoconazole. J Eur Acad Dermatol 8:69\u201370","journal-title":"J Eur Acad Dermatol"},{"key":"1009_CR117","first-page":"209","volume":"38","author":"Veien","year":"1986","unstructured":"Veien NK, Christiansen JV, Hjorth N, Schmidt H (1986) Topical metronidazole in the treatment of rosacea. Cutis 38:209\u2013210","journal-title":"Cutis"},{"key":"1009_CR118","first-page":"646","volume":"58","author":"Vogt","year":"1982","unstructured":"Vogt E, Friedrich HC (1982) Orale 13-cis-Retins\u00e4ure-Therapie bei Adenoma sebaceum symmetricum und schwerster Akne- und Rosazeaform. Z Hautk 58:646\u2013667","journal-title":"Z Hautk"},{"key":"1009_CR119","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/1523-1747.ep12524458","volume":"76","author":"Wilkin","year":"1981","unstructured":"Wilkin J (1981) Oral thermal-induced flushing in erythematotelangiectatic rosacea. J Invest Dermatol 76:15\u201318","journal-title":"J Invest Dermatol"},{"key":"1009_CR120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archderm.1983.01650270029012","volume":"119","author":"Wilkin","year":"1983","unstructured":"Wilkin JK (1983) Effect of subdepressor clonidine of flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions. Arch Dermatol 119:211\u2013214","journal-title":"Arch Dermatol"},{"key":"1009_CR121","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0190-9622(89)70022-0","volume":"20","author":"Wilkins","year":"1989","unstructured":"Wilkins JK (1989) Effect of nadolol on flushing reactions in rosacea. J Am Acad Dermatol 20:202\u2013205","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR122","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-4362.1993.tb00974.x","volume":"32","author":"Wilkin","year":"1993","unstructured":"Wilkin JK, DeWitt S (1993) Treatment of rosacea. Topical clindamycin versus oral tetracycline. Int J Dermatol 32:65\u201367","journal-title":"Int J Dermatol"},{"key":"1009_CR123","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1994.01690030091015","volume":"130","author":"Wilkin","year":"1994","unstructured":"Wilkin JK (1994) Rosacea: pathophysiology and treatment. Arch Dermatol 130:359\u2013362","journal-title":"Arch Dermatol"},{"key":"1009_CR124","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archderm.135.1.79","volume":"135","author":"Wilkin","year":"1999","unstructured":"Wilkin JK (1999) Use of topical products for maintaining remission in rosaccea. Arch Dermatol 135:79\u201380","journal-title":"Arch Dermatol"},{"key":"1009_CR125","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","volume":"45","author":"Wilkin","year":"2002","unstructured":"Wilkin J, Dahl M, Detmar M et al. (2002) Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 45:584\u2013587","journal-title":"J Am Acad Dermatol"},{"key":"1009_CR126","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2004.08.061","volume":"52","author":"Wohlrab","year":"2005","unstructured":"Wohlrab J, Lueftl M, Marsch WC (2005) Persistent erythema and edema of the midthird and upper aspect of the face (morbus morbihan): evidence of hidden immunologic contact urticaria and impaired lymphatic drainage. J Am Acad Dermatol 52:595\u2013602","journal-title":"J Am Acad Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-005-1009-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-005-1009-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-005-1009-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T03:59:45Z","timestamp":1706500785000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-005-1009-3"}},"subtitle":["Klinik, Pathogenese, Therapie","Clinical features, pathogenesis and therapy"],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":126,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["1009"],"URL":"https:\/\/doi.org\/10.1007\/s00105-005-1009-3","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}